“Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives As Potential CYP51B Inhibitors Against Aspergillus Fumigatus”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 26, no. 3, Sept. 2026, pp. 302-15, https://doi.org/10.32947/ajps.v26i3.1420.